Kingsview Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Kingsview Wealth Management's LLY Position: Q2 2026 in Review
Kingsview Wealth Management increased its Eli Lilly (LLY) stake by 8.8% in Q2 2026, buying an estimated $6.76M and bringing the position to 82,083 shares worth $98.5M. The position accounts for 1.19% of the portfolio, ranked #13.
Kingsview Wealth Management first reported a position in LLY in Q3 2018 and has held it in 32 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Kingsview Wealth Management held 82,083 shares of Eli Lilly worth $98.5M as of Q2 2026.
- Kingsview Wealth Management bought 6,612 Eli Lilly shares in Q2 2026, an estimated $6.76M.
- Eli Lilly made up 1.19% of Kingsview Wealth Management's portfolio in Q2 2026, its #13 holding.
- Kingsview Wealth Management first reported a position in Eli Lilly in Q3 2018 and has held it in 32 quarters since.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.